Search details
1.
Trastuzumab deruxtecan in patients with human epidermal growth factor receptor 2-expressing salivary gland carcinoma: a pooled analysis of two phase I studies.
Jpn J Clin Oncol
; 54(4): 434-443, 2024 Apr 06.
Article
in English
| MEDLINE | ID: mdl-38231777
2.
Trastuzumab deruxtecan in patients with locally advanced or metastatic HER2-positive gastric cancer: a multicenter, open-label, expanded-access study.
Int J Clin Oncol
; 29(1): 27-35, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-37964066
3.
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer.
N Engl J Med
; 382(25): 2419-2430, 2020 06 18.
Article
in English
| MEDLINE | ID: mdl-32469182
4.
Prospective analysis of the expression status of FGFR2 and HER2 in colorectal and gastric cancer populations: DS-Screen Study.
Int J Colorectal Dis
; 37(6): 1393-1402, 2022 Jun.
Article
in English
| MEDLINE | ID: mdl-35585358
5.
[A Case of Second Primary Small Cell Lung Carcinoma after Radiotherapy for Breast Cancer].
Gan To Kagaku Ryoho
; 49(12): 1361-1364, 2022 Dec.
Article
in Japanese
| MEDLINE | ID: mdl-36539250
6.
A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors.
Invest New Drugs
; 38(1): 99-110, 2020 02.
Article
in English
| MEDLINE | ID: mdl-30825104
7.
Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive gastric cancer: a dose-expansion, phase 1 study.
Lancet Oncol
; 20(6): 827-836, 2019 06.
Article
in English
| MEDLINE | ID: mdl-31047804
8.
Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 study.
Lancet Oncol
; 20(6): 816-826, 2019 06.
Article
in English
| MEDLINE | ID: mdl-31047803
9.
Impact of Additional Lipid-Lowering Therapy on New Ischemic Lesions of Diffusion-Weighted Imaging in Carotid Artery Stenting.
J Stroke Cerebrovasc Dis
; 27(3): 764-770, 2018 Mar.
Article
in English
| MEDLINE | ID: mdl-29103862
10.
The relationship between low-density lipoprotein cholesterol levels and the incidence of cardiovascular disease in high-risk patients treated with pravastatin: main results of the APPROACH-J study.
Int Heart J
; 55(1): 39-47, 2014.
Article
in English
| MEDLINE | ID: mdl-24463915
11.
Serum CYFRA 21-1 Level as a Prognostic Marker for Extensive Disease Small Cell Lung Cancer.
Anticancer Res
; 44(2): 845-851, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38307561
12.
Stereotactic radiotherapy of radiation-induced meningioma previously irradiated retrobulbar for Graves' ophthalmopathy: A case report.
Radiol Case Rep
; 19(3): 895-900, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38188958
13.
A vertebrobasilar junction aneurysm successfully treated with a combination of surgical clipping and flow diverter placement based on the results of computational fluid dynamics analysis: illustrative case.
J Neurosurg Case Lessons
; 7(10)2024 Mar 04.
Article
in English
| MEDLINE | ID: mdl-38437674
14.
Trastuzumab deruxtecan in HER2-positive advanced gastric cancer: exploratory biomarker analysis of the randomized, phase 2 DESTINY-Gastric01 trial.
Nat Med
; 2024 May 14.
Article
in English
| MEDLINE | ID: mdl-38745009
15.
Advanced hepatocellular carcinoma with lymph node metastases showing epithelial to mesenchymal transition effectively treated with systemic chemotherapy: Report of a case.
Hepatol Res
; 43(12): 1368-73, 2013 Dec.
Article
in English
| MEDLINE | ID: mdl-23607775
16.
Combined transarterial and transvenous embolization of anterior cranial fossa dural arteriovenous fistula.
Surg Neurol Int
; 14: 277, 2023.
Article
in English
| MEDLINE | ID: mdl-37680916
17.
Lung Cancer Complicated by Relapsing Polychondritis.
Intern Med
; 62(7): 1049-1054, 2023 Apr 01.
Article
in English
| MEDLINE | ID: mdl-36070940
18.
Clinical activity of crizotinib in lung adenocarcinoma harboring a HLA_AROS1 rearrangement: A case report.
Oncol Lett
; 26(6): 515, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37927416
19.
Trastuzumab Deruxtecan in Anti-Human Epidermal Growth Factor Receptor 2 Treatment-Naive Patients With Human Epidermal Growth Factor Receptor 2-Low Gastric or Gastroesophageal Junction Adenocarcinoma: Exploratory Cohort Results in a Phase II Trial.
J Clin Oncol
; 41(4): 816-825, 2023 02 01.
Article
in English
| MEDLINE | ID: mdl-36379002
20.
Significance of blood aspiration in carotid artery stenting with Angioguard XP.
J Vasc Surg
; 53(6): 1478-84, 2011 Jun.
Article
in English
| MEDLINE | ID: mdl-21515015